Acer Therapeutics Inc (NASDAQ:ACER)

2.11
BATS BZX Real-Time Price
As of 10:07am ET
 +0.05 / +2.43%
Today’s Change
1.08
Today|||52-Week Range
28.25
-47.38%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +326.54% increase from the last price of 2.11.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Acer Therapeutics Inc. This rating has held steady since February, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.40
Sales
$0.00
Reporting Date
May 19

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.57%
 
 
 
 
 
 
Growthannually 59.18%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.